Author： Braun J. Baraliakos X. Godolias G. Böhm H.
Publisher： Informa Healthcare
ISSN： 0300-9742
Source： Scandinavian Journal of Rheumatology, Vol.34, Iss.2, 2005-04, pp. : 97-108
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience
By Konttinen Liisa Tuompo Riitta Uusitalo Tea Luosujärvi Riitta Laiho Kari Lähteenmäki Jukka Puurtinen-Vilkki Maija Lanteri Ritva Kortelainen Saara Karilainen Helena Varjolahti-Lehtinen Tuire Nordström Dan
Clinical Rheumatology, Vol. 26, Iss. 10, 2007-10 ,pp. :
Adalimumab: effective TNF-blockade therapy for ankylosing spondylitis
By Schwab Pascale Deodhar Atul
Future Rheumatology, Vol. 2, Iss. 5, 2007-10 ,pp. :
Demyelination during anti-TNFα therapy for ankylosing spondylitis
Modern Rheumatology, Vol. 22, Iss. 2, 2012-04 ,pp. :
Anti-TNF-αα therapy for ankylosing spondylitis
By Frech Tracy
Future Rheumatology, Vol. 2, Iss. 5, 2007-10 ,pp. :